Odour identification as a marker for postoperative cognitive dysfunction: A pilot study

Anaesthesia

Volumn 59, Issue 4, 2004, Pages 337-343

  Rentowl, P ^a   Hanning, Chris D ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer disease; Odours; Postoperative complications: Cognitive dysfunction

Indexed keywords

BIOLOGICAL MARKER;

ABDOMINAL SURGERY; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; FEMALE; GENERAL ANESTHESIA; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MINI MENTAL STATE EXAMINATION; OLFACTORY DISCRIMINATION; ORTHOPEDIC SURGERY; PILOT STUDY; PSYCHOMETRY; RISK FACTOR; SURGICAL PATIENT; THORAX SURGERY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANESTHESIA, GENERAL; APOLIPOPROTEINS E; COGNITION DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ODORS; OLFACTION DISORDERS; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PSYCHOMETRICS;

EID: 1842844360     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2004.03678.x     Document Type: Article

References (39)

1. Newman MF, Kirchner JL, Phillips-Bute B et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. New England Journal of Medicine 2001; 344: 395-402.
2. Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study. Lancet 1998; 351: 857-61.
3. Abildstrom H, Rasmussen LS, Rentowl P, et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. Acta Anaethesiologica Scandinavica 2000; 44: 1246-51.
4. Selnes OA, Royall RM, Grega MA, Borowicz LM Jr, Quaskey S, McKhann GM. Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? Archives of Neurology 2001; 58: 598-604.
5. Aberg T, Ahlund P, Kihlgren M. Intellectual function late after open-heart operation. Annals of Thoracic Surgery 1983; 36: 680-3.
6. Sotaniemi KA, Mononen H, Hokkanen TE. Long-term cerebral outcome after open heart surgery: a five-year neuropsychological follow-up study. Stroke 1986; 17: 410-6.
7. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54 (11 Suppl. 5): S4-9.
8. Bedford PD. Adverse cerebral effects of anaesthesia on old people. Lancet 1955; ii: 259-63.
9. Newman MF, Narda D, Croughwell ND, et al. Predictors of cognitive decline after cardiac operation. Annals of Thoracic Surgery 1995; 59: 1326-30.
10. Ritchie K, Polge C, de Roquefeuil G, Djakovic M, Ledesert B. Impact of anesthesia on the cognitive fuctioning of the elderly. International Psychogeriatrics 1997; 9: 309-26.
11. Roman GC. Vascular dementia may be the most common form of dementia in the elderly. Journal of the Neurological Sciences 2002; 203-204: 7-10.
12. Pfitzenmeyer P, Musat A, Lenfant L, Turcu A, Musat A. Postoperative cognitive disorders in the elderly. Presse Medicale 2001; 30: 648-52.
13. Neugroschl J, Davis KL. Biological markers in Alzheimer disease. American Journal of Geriatric Psychiatry 2002; 10: 660-77.
14. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Research Bulletin 1987; 18: 597-600.
15. Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. American Journal of Psychiatry 1991; 148: 357-60.
16. Gray AJ, Staples V, Murren K, Dhariwal A, Bentham P. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. International Journal of Geriatric Psychiatry 2001; 16: 513-7.
17. Devanand DP, Michaels-Marston KS, Liu X, et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. American Journal of Psychiatry 2000; 157: 1399-405.
18. Evans D, Beckett L, Field T, et al. Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. Journal of the American Medical Association 1997; 277: 822-4.
19. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. Journal of the American Medical Association 1997; 278: 1349-56.
20. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Archives of Neurology 1998; 55: 964-8.
21. Juottonen K, Lehtovirta M, Helisalmi S, Riekkinen PJSr, Soininen H. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E ε4 allele. Journal of Neurology, Neurosurgery and Psychiatry 1998; 65: 322-7.
22. Murphy C, Bacon AW, Bondi MW, Salmon DP. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Annals of the New York Academy of Sciences 1998; 855: 744-50.
23. Graves AB, Bowen JD, Rajaram. L, et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E ε4 status. Neurology 1999; 53: 1480-7.
24. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S. Apolipoprotein E ε4 associated with chronic traumatic brain injury in boxing. Journal of the American Medical Association 1997; 278: 136-40.
25. Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350: 1069-71.
26. Laskowitz DT, Horsburgh K, Roses AD. Apolipoprotein E and the CNS response to injury. Journal of Cerebral Blood Flow and Metabolism 1998; 18: 465-71.
27. Tardiff BE, Newman MF, Saunders AM, et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. Annals of Thoracic Surgery 1997; 64: 715-20.
28. Steed L, Kong R, Stygall J, et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Annals of Thoracic Surgery 2001; 71: 823-6.
29. Folstein MF, Folstein SE, McHough PR. Mini-Mental State. a practical method for grading the cognitive status of patients for the clinician. Journal of Psychiatric Research 1975; 12: 189-98.
30. Brand N, Jolles J. Learning and retrieval rate of words presented auditorily and visually. Journal of General Psychology 1985; 112: 201-10.
31. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual Motor Skills 1958; 8: 271-6.
32. Bohnen N, Twijnstra A, Jolles J. Performance in the Stroop Color Word Test in relationship to the persistence of symptoms following mild head injury. Acta Neurologica Scandinavica 1992; 85: 116-21.
33. Lezak MD. Neuropsychological Assessment, 3rd edn. New York: Oxford University Press, 1995: 379-81.
34. Wolfensberger M, Hummel T. Anti-inflammatory and surgical therapy of olfactory disorders related to sino-nasal disease. Chemical Senses 2002; 27: 617-22.
35. Frasnelli JA, Temmel AF, Quint C, Oberbauer R, Hummel T. Olfactory function in chronic renal failure. American Journal of Rhinology 2002; 16: 275-9.
36. Suzuki Y, Critchley HD, Rowe A, Howlin P, Murphy DG. Impaired olfactory identification in Asperger's syndrome. Journal of Neuropsychiatry and Clinical Neurosciences 2003; 15: 105-7.
37. Hawkes C. Olfaction in neurodegenerative disorder. Movement Disorders 2003; 18: 364-72.
38. Lee AC, Rahman S, Hodges JR, Sahakian B, Graham KS. Associative and recognition memory for novel objects in dementia: implications for diagnosis. European Journal of Neuroscience 2003; 18: 1660-70.
39. Nagy Z, Combrinck M, Budge M, McShane R. Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Neuroscience Letters 2002; 317: 81-4.